221 related articles for article (PubMed ID: 34139918)
21. Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechanisms.
Cifarelli V; Lashinger LM; Devlin KL; Dunlap SM; Huang J; Kaaks R; Pollak MN; Hursting SD
Diabetes; 2015 May; 64(5):1632-42. PubMed ID: 25576058
[TBL] [Abstract][Full Text] [Related]
22. Metformin Treatment for the Prevention and/or Treatment of Breast/Mammary Tumorigenesis.
Grossmann ME; Yang DQ; Guo Z; Potter DA; Cleary MP
Curr Pharmacol Rep; 2015 Apr; 1(5):312-323. PubMed ID: 26405648
[TBL] [Abstract][Full Text] [Related]
23. Metformin and Anti-Cancer Therapeutics: Hopes for a More Enhanced Armamentarium Against Human Neoplasias?
Christodoulou MI; Scorilas A
Curr Med Chem; 2017; 24(1):14-56. PubMed ID: 27604091
[TBL] [Abstract][Full Text] [Related]
24. Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells.
Cai H; Zhang Y; Han TK; Everett RS; Thakker DR
Int J Cancer; 2016 May; 138(9):2281-92. PubMed ID: 26669511
[TBL] [Abstract][Full Text] [Related]
25. Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells.
Klubo-Gwiezdzinska J; Jensen K; Costello J; Patel A; Hoperia V; Bauer A; Burman KD; Wartofsky L; Vasko V
Endocr Relat Cancer; 2012 Jun; 19(3):447-56. PubMed ID: 22389381
[TBL] [Abstract][Full Text] [Related]
26. The role of AMPK/mTOR signaling pathway in anticancer activity of metformin.
Chomanicova N; Gazova A; Adamickova A; Valaskova S; Kyselovic J
Physiol Res; 2021 Aug; 70(4):501-508. PubMed ID: 34062070
[TBL] [Abstract][Full Text] [Related]
27. Metformin Prevents Hyperglycemia-Associated, Oxidative Stress-Induced Vascular Endothelial Dysfunction: Essential Role for the Orphan Nuclear Receptor Human Nuclear Receptor 4A1 (Nur77).
Venu VKP; Saifeddine M; Mihara K; Faiza M; Gorobets E; Flewelling AJ; Derksen DJ; Hirota SA; Marei I; Al-Majid D; Motahhary M; Ding H; Triggle CR; Hollenberg MD
Mol Pharmacol; 2021 Nov; 100(5):428-455. PubMed ID: 34452975
[TBL] [Abstract][Full Text] [Related]
28. Convergence of IPMK and LKB1-AMPK signaling pathways on metformin action.
Bang S; Chen Y; Ahima RS; Kim SF
Mol Endocrinol; 2014 Jul; 28(7):1186-93. PubMed ID: 24877601
[TBL] [Abstract][Full Text] [Related]
29. Regulation of organelle function by metformin.
Kim J; You YJ
IUBMB Life; 2017 Jul; 69(7):459-469. PubMed ID: 28444922
[TBL] [Abstract][Full Text] [Related]
30. Metformin inhibits follicle-stimulating hormone (FSH) action in human granulosa cells: relevance to polycystic ovary syndrome.
Rice S; Elia A; Jawad Z; Pellatt L; Mason HD
J Clin Endocrinol Metab; 2013 Sep; 98(9):E1491-500. PubMed ID: 23846817
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
[TBL] [Abstract][Full Text] [Related]
32. Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer.
Schuler KM; Rambally BS; DiFurio MJ; Sampey BP; Gehrig PA; Makowski L; Bae-Jump VL
Cancer Med; 2015 Feb; 4(2):161-73. PubMed ID: 25417601
[TBL] [Abstract][Full Text] [Related]
33. Metformin and Prostate Cancer: a New Role for an Old Drug.
Whitburn J; Edwards CM; Sooriakumaran P
Curr Urol Rep; 2017 Jun; 18(6):46. PubMed ID: 28444639
[TBL] [Abstract][Full Text] [Related]
34. Metformin and Angiogenesis in Cancer - Revisited.
Kannarkatt J; Alkharabsheh O; Tokala H; Dimitrov NV
Oncology; 2016; 91(4):179-184. PubMed ID: 27487294
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy.
Shi WY; Xiao D; Wang L; Dong LH; Yan ZX; Shen ZX; Chen SJ; Chen Y; Zhao WL
Cell Death Dis; 2012 Mar; 3(3):e275. PubMed ID: 22378068
[TBL] [Abstract][Full Text] [Related]
36. Anti-diabetic drug metformin: challenges and perspectives for cancer therapy.
Snima KS; Pillai P; Cherian AM; Nair SV; Lakshmanan VK
Curr Cancer Drug Targets; 2014; 14(8):727-36. PubMed ID: 25329671
[TBL] [Abstract][Full Text] [Related]
37. High dose targeted delivery on cancer sites and the importance of short-chain fatty acids for metformin's action: Two crucial aspects of the wonder drug.
Maniar K; Singh V; Chakrabarti A; Bhattacharyya R; Banerjee D
Regul Toxicol Pharmacol; 2018 Aug; 97():15-16. PubMed ID: 29857113
[TBL] [Abstract][Full Text] [Related]
38. [Metformin's effect on 5-fluorouracil,cisplatin,paclitaxel in laryngocarcinoma Hep-2 cells].
Zhou CY; Li XM; Shan S; Jia LF; Huang ZL
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Apr; 31(7):524-528. PubMed ID: 29871302
[No Abstract] [Full Text] [Related]
39. Metformin Induces Oxidative Stress-Mediated Apoptosis without the Blockade of Glycolysis in H4IIE Hepatocellular Carcinoma Cells.
Park D
Biol Pharm Bull; 2019; 42(12):2002-2008. PubMed ID: 31787716
[TBL] [Abstract][Full Text] [Related]
40. Understanding the benefit of metformin use in cancer treatment.
Dowling RJ; Goodwin PJ; Stambolic V
BMC Med; 2011 Apr; 9():33. PubMed ID: 21470407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]